Use of the Unstable Shoes in Lower Limb Lymphedema.
Effectiveness of Unstable Shoes on Volume and Quality of Life in Lower Limb Lymphedema.
1 other identifier
interventional
26
0 countries
N/A
Brief Summary
Lymphedema is an external manifestation of lymphatic system insufficiency and deranged lymph transport. It is defined as accumulation in the extracellular space of protein-rich fluid, due to a mechanical failure of the lymphatic system. Lymphedema directly affects the quality of life of the patient, not only in the physical aspect, but also in the psychological, sexual and social aspects. Muscle and joint pumps are important external mechanisms of lymphatic and venous fluid return improvement. The unstable shoes demands, especially during standing, increased muscle activity in the lower extremities. A clinical trial was carried out comparing both kinds of footwear, the objective being to evaluate possible differences in the evolution of lymphedema. Unstable shoes (MBT®) were compared with conventional sports shoes. During a clinical trial lasting eight weeks, we assessed quality of life, limb volume, and symptoms derived from lymphedema. The results suggested that the use of unstable shoes is recommendable for walking and for long periods of standing, since it decreases leg cramping and paraesthesia of affected limbs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2013
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2017
CompletedFirst Submitted
Initial submission to the registry
July 28, 2023
CompletedFirst Posted
Study publicly available on registry
August 18, 2023
CompletedAugust 18, 2023
August 1, 2023
2.7 years
July 28, 2023
August 10, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Volume of the lower limb
Volume of the lower limb
8 weeks
Secondary Outcomes (2)
Circumference measure of the foot
8 weeks
Changes in lymphedema symptoms
8 weeks
Study Arms (2)
Unstable shoes
EXPERIMENTALUse of unstable shoes for 8 weeks
Usual sports footwear
NO INTERVENTIONUse of conventional shoes for 8 weeks
Interventions
Unstable shoes were compared with conventional sports shoes, the objective being to evaluate possible differences in the evolution of lymphedema. During a clinical trial lasting eight weeks, we assessed quality of life, limb volume, and symptoms derived from lymphedema.
Eligibility Criteria
You may qualify if:
- Subjects affected with lower limb lymphedema -primary, secondary, unilateral or bilateral-, -Daily use of a compression stocking
You may not qualify if:
- Subjects with acute infection of the affected limb
- that did not had any treatment for lymphedema one year prior to the study,
- Weight \<40kg,
- shoe size \<EU35 or \>EU47
- that have previously used unstable shoes
- vestibular alterations, vertigo, hypoacusis
- visual compromise that affects balanc
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
July 28, 2023
First Posted
August 18, 2023
Study Start
November 1, 2013
Primary Completion
June 30, 2016
Study Completion
June 30, 2017
Last Updated
August 18, 2023
Record last verified: 2023-08